New inhibitor of 3-phosphoinositide dependent protein kinase-1 identified from virtual screening
- PMID: 22266037
- PMCID: PMC4371734
- DOI: 10.1016/j.bmcl.2011.12.121
New inhibitor of 3-phosphoinositide dependent protein kinase-1 identified from virtual screening
Abstract
3-Phosphoinositide-dependent protein kinase-1 (PDK1) has been recognized as a promising anticancer target. Thus, it is interesting to identify new inhibitors of PDK1 for anticancer drug discovery. Through a combined use of virtual screening and wet experimental activity assays, we have identified a new PDK1 inhibitor with IC(50)=~200 nM. The anticancer activities of this compound have been confirmed by the anticancer activity assays using 60 cancer cell lines. The obtained new PDK1 inhibitor and its PDK1-inhibitor binding mode should be valuable in future de novo design of novel, more potent and selective PDK1 inhibitors for future development of anticancer therapeutics.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Figures
Similar articles
-
Novel small molecule inhibitors of 3-phosphoinositide-dependent kinase-1.J Biol Chem. 2005 May 20;280(20):19867-74. doi: 10.1074/jbc.M501367200. Epub 2005 Mar 16. J Biol Chem. 2005. PMID: 15772071
-
Structure-based design of potent and selective 3-phosphoinositide-dependent kinase-1 (PDK1) inhibitors.J Med Chem. 2011 Mar 24;54(6):1871-95. doi: 10.1021/jm101527u. Epub 2011 Feb 22. J Med Chem. 2011. PMID: 21341675
-
Identification of Novel Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors by Kinase Activity-Based High-Throughput Screening for Anticancer Therapeutics.ACS Comb Sci. 2018 Nov 12;20(11):660-671. doi: 10.1021/acscombsci.8b00104. Epub 2018 Oct 23. ACS Comb Sci. 2018. PMID: 30350563
-
PDK1 and PKB/Akt: ideal targets for development of new strategies to structure-based drug design.IUBMB Life. 2003 Mar;55(3):117-26. doi: 10.1080/1521654031000115951. IUBMB Life. 2003. PMID: 12822887 Review.
-
A patent update on PDK1 inhibitors (2015-present).Expert Opin Ther Pat. 2019 Apr;29(4):271-282. doi: 10.1080/13543776.2019.1597852. Epub 2019 Mar 29. Expert Opin Ther Pat. 2019. PMID: 30897008 Review.
Cited by
-
TPCK inhibits AGC kinases by direct activation loop adduction at phenylalanine-directed cysteine residues.FEBS Lett. 2012 Sep 21;586(19):3471-6. doi: 10.1016/j.febslet.2012.07.075. Epub 2012 Aug 10. FEBS Lett. 2012. PMID: 22967899 Free PMC article.
-
Novel mycosin protease MycP₁ inhibitors identified by virtual screening and 4D fingerprints.J Chem Inf Model. 2014 Apr 28;54(4):1166-73. doi: 10.1021/ci500025r. Epub 2014 Mar 27. J Chem Inf Model. 2014. PMID: 24628123 Free PMC article.
-
Assessing the regioselectivity of OleD-catalyzed glycosylation with a diverse set of acceptors.J Nat Prod. 2013 Feb 22;76(2):279-86. doi: 10.1021/np300890h. Epub 2013 Jan 29. J Nat Prod. 2013. PMID: 23360118 Free PMC article.
-
Target-Based Small Molecule Drug Discovery for Colorectal Cancer: A Review of Molecular Pathways and In Silico Studies.Biomolecules. 2022 Jun 23;12(7):878. doi: 10.3390/biom12070878. Biomolecules. 2022. PMID: 35883434 Free PMC article. Review.
-
Integrating sampling techniques and inverse virtual screening: toward the discovery of artificial peptide-based receptors for ligands.Mol Divers. 2016 May;20(2):421-38. doi: 10.1007/s11030-015-9648-5. Epub 2015 Nov 9. Mol Divers. 2016. PMID: 26553204
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Chemical Information
Miscellaneous